Elanco agrees to divest another medication
Elanco Animal Health has agreed to divest the U.S. rights to Capstar, an oral tablet that kills fleas in dogs and cats, to pet medication company PetIQ, for $95 million in an all-cash deal. The product had 2018 revenue of…